Literature DB >> 11319801

Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.

M D Odero1, K Carlson, M J Calasanz, I Lahortiga, V Chinwalla, J D Rowley.   

Abstract

TEL/ETV6 is the first transcription factor identified that is specifically required for hematopoiesis within the bone marrow. This gene has been found to have multiple fusion partners; 35 different chromosome bands have been involved in ETV6 translocations, of which 13 have been cloned. To identify additional ETV6 partner genes and to characterize the chromosomal abnormalities more fully, we studied bone marrow samples from patients known to have rearrangements of 12p, using fluorescence in situ hybridization (FISH) and spectral karyotyping (SKY). FISH analysis was done with 14 probes located on 12p12.1 to 12p13.3. Nine ETV6 rearrangements were identified using FISH. The aberrations include t(1;12)(p36;p13), t(4;12)(q12;p13) (two patients), t(4;12)(q22;p13), t(6;12)(p21;p13), der(6)t(6;21)(q15;q?)t(12;21)(p13;q22), t(6;12)(q25;p13), inv(12)(p13q24), and t(2;2;5;12;17)(p25;q23;q31;p13;q12). Six new ETV6 partner bands were identified: 1p36, 4q22, 6p21, 6q25, 12q24, and 17q12. Our present data as well previous data from us and from other researchers suggest that ETV6 is involved in 41 translocations. The breakpoints in ETV6 were upstream from the exons coding for the HLH (helix-loop-helix) domain in six cases. Although cytogenetic analysis identified 12p abnormalities in all cases, FISH and SKY detected new and unexpected chromosomal rearrangements in many of them. Thus, complete characterization of the samples was achieved by using all three techniques in combination. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319801     DOI: 10.1002/gcc.1127

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  Anti-apoptotic protein BCL2 down-regulates DNA end joining in cancer cells.

Authors:  Tadi Satish Kumar; Vijayalakshmi Kari; Bibha Choudhary; Mridula Nambiar; T S Akila; Sathees C Raghavan
Journal:  J Biol Chem       Date:  2010-08-10       Impact factor: 5.157

2.  TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia.

Authors:  Hatem E Sabaawy; Mizuki Azuma; Lisa J Embree; Huai-Jen Tsai; Matthew F Starost; Dennis D Hickstein
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

3.  ETV6 mutation in a cohort of 970 patients with hematologic malignancies.

Authors:  Qinrong Wang; Shasha Dong; Hong Yao; Lijun Wen; Huiying Qiu; Llili Qin; Liang Ma; Suning Chen
Journal:  Haematologica       Date:  2014-07-04       Impact factor: 9.941

Review 4.  Transcription factor mutations as a cause of familial myeloid neoplasms.

Authors:  Jane E Churpek; Emery H Bresnick
Journal:  J Clin Invest       Date:  2019-02-01       Impact factor: 14.808

5.  Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia.

Authors:  Vijay P S Rawat; Monica Cusan; Aniruddha Deshpande; Wolfgang Hiddemann; Leticia Quintanilla-Martinez; R Keith Humphries; Stefan K Bohlander; Michaela Feuring-Buske; Christian Buske
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

Review 6.  Genetic and epigenetic alterations of myeloproliferative disorders.

Authors:  Jelena D Milosevic; Robert Kralovics
Journal:  Int J Hematol       Date:  2012-12-12       Impact factor: 2.490

7.  t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity.

Authors:  Sarah B Mueller; Paola Dal Cin; Long P Le; Dora Dias-Santagata; Jochen K Lennerz; A John Iafrate; Hetal Desai Marble; Andrew M Brunner; Matthew J Weinstock; Marlise R Luskin; Daniel J De Angelo; Richard M Stone; Valentina Nardi
Journal:  Blood Adv       Date:  2022-01-08

8.  FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome.

Authors:  Idoya Lahortiga; Iria Vázquez; Elena Belloni; José P Román; Patrizia Gasparini; Francisco J Novo; Isabel Zudaire; Pier G Pelicci; Jesús M Hernández; María J Calasanz; María D Odero
Journal:  Hum Genet       Date:  2005-03-03       Impact factor: 4.132

Review 9.  Genetic basis of MPN: Beyond JAK2-V617F.

Authors:  Nicole C C Them; Robert Kralovics
Journal:  Curr Hematol Malig Rep       Date:  2013-12       Impact factor: 3.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.